Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors.
Roberta SanfilippoChiara FabbroniGiovanni FucàElena FumagalliCarlo MorosiMarta SbaragliaAlessandro GronchiPaola ColliniAngelo Paolo Dei TosPaolo G CasaliPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
In this small retrospective case series, the addition of antiestrogen treatment in female patients with advanced PEComa progressing to mTOR inhibitors resulted in a remarkable clinical benefit in a setting where no other options are available.
Keyphrases